-
"The Role of Rimonabant in the Management of treatment-naïve type 2 diabetes patients"
-
First half of 2006: Sales growth of 7.7% on a reported basis and 4.5% on a comparable basis1 Adjusted EPS1 growth of 32.9%, or 16.1% excluding selected items3
-
Results 1st half 2006
-
Sanofi-aventis responds to the emergency request for humanitarian aid to Lebanon
Visa mer
Loading...